Product image of Kyleena (Levonorgestrel) supplied by GNH India

Kyleena

Active Ingredient:
Levonorgestrel
Origin:
EU

Kyleena (Levonorgestrel)

Levonorgestrel, the active ingredient in Kyleena, is a progestin presented as a 19.5 mg intrauterine system (IUS) for intrauterine use. It provides long‑acting hormonal contraception for women of reproductive age, preventing pregnancy by inhibiting ovulation and altering cervical mucus and endometrium.

GNH India supplies Kyleena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. The company provides reliable logistics and documentation for cross‑border procurement.

Manufacturer / TM Owner

Bayer Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Kyleena, a levonorgestrel intrauterine system, is used in hormonal contraception to provide long‑acting reversible birth control.
  • Contraception (prevention of pregnancy): provides highly effective, reversible birth control for women of reproductive age.
  • Long‑acting reversible contraception (LARC): delivers continuous levonorgestrel release for up to five years.
  • Reduction of menstrual bleeding: can lessen menstrual flow and related symptoms in many users.

How It Works

  • Levonorgestrel released from the intrauterine system diffuses locally into the uterine cavity, where it binds to progesterone receptors in the endometrium and cervical mucus. This binding suppresses the mid‑cycle luteinizing hormone surge, preventing ovulation, while simultaneously thickening cervical mucus and inducing endometrial atrophy, creating an environment unsuitable for fertilization and implantation.

Side Effects

Kyleena may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Irregular bleeding or spotting
  • Amenorrhea (absence of periods)
  • Cramps or pelvic pain
  • Headache
  • Breast tenderness

Serious or Rare Side Effects

  • Uterine perforation
  • Expulsion of the device
  • Pelvic inflammatory disease (PID)

Precautions & Warnings

  • When prescribing Kyleena, clinicians should consider several precautionary measures to ensure safe use.
  • Screen for pregnancy: confirm patient is not pregnant before insertion.
  • Assess uterine abnormalities: evaluate for fibroids, congenital anomalies, or active infection.
  • Consider hormonal sensitivity: discuss potential side effects with patients having a history of hormone‑related disorders.
  • Monitor for device displacement: schedule follow‑up visits to confirm correct positioning.
  • Store at room temperature: keep the device in its original packaging, protect from moisture and extreme heat.

Avoid Interactions

Levonorgestrel IUS may interact with other agents that affect hormonal balance or uterine environment.

Major Interactions (Avoid)

  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce levonorgestrel efficacy.
  • Rifampin or other strong CYP3A4 inducers: can lower hormone levels.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): may increase levonorgestrel exposure.
  • Antiretroviral therapy (e.g., protease inhibitors): potential pharmacokinetic changes.
  • Herbal supplements containing St. John’s wort: may modestly decrease effectiveness.

Frequently Asked Questions

Kyleena is a levonorgestrel intrauterine system indicated for long‑acting hormonal contraception. It provides reversible birth control for women of reproductive age by preventing ovulation, thickening cervical mucus, and altering the endometrium to inhibit implantation.

Levonorgestrel released from the intrauterine system binds to progesterone receptors in the uterus, suppressing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus and induces endometrial atrophy, creating conditions that prevent fertilisation and implantation.

Kyleena is supplied as a single‑use intrauterine device containing 19.5 mg of levonorgestrel. The prescriber determines the need for insertion and the duration of use; no daily dosing regimen is required from the patient.

Kyleena is contraindicated in pregnancy and is classified as Pregnancy Category X. It should not be inserted in a pregnant woman. For breastfeeding, the device may be used after insertion, but clinicians should discuss any concerns with the patient.

To order Kyleena, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Kyleena contains a lower levonorgestrel dose (19.5 mg) than some alternatives such as Mirena, offering up to five years of contraception with a smaller device profile. Efficacy is comparable, while the reduced hormone load may result in fewer hormonal side effects for some users.

Kyleena should be stored at room temperature, below 25 °C, in its original packaging. Protect the device from moisture, direct sunlight and extreme heat to maintain its integrity until insertion.

Kyleena is inserted by a trained healthcare professional into the uterine cavity using a specialised inserter. The procedure is performed in a clinical setting under aseptic conditions, and the device remains in place for up to five years unless removal is required.

Serious risks include uterine perforation during insertion, expulsion of the device, and pelvic inflammatory disease (PID). Patients should be monitored for severe abdominal pain, abnormal bleeding, or signs of infection and seek medical attention promptly if they occur.

Kyleena should not be used by women who are pregnant, have active pelvic infection, untreated cervical or uterine cancer, unexplained vaginal bleeding, or significant uterine abnormalities such as large fibroids or congenital malformations.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT